4//SEC Filing
Macrae Sandy 4
Accession 0001415889-25-002018
CIK 0001001233other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:05 PM ET
Size
6.2 KB
Accession
0001415889-25-002018
Insider Transaction Report
Form 4
Macrae Sandy
DirectorPRESIDENT, CEO AND DIRECTOR
Transactions
- Tax Payment
Common Stock
2025-01-22$1.15/sh−412,584$474,472→ 2,095,999 total
Footnotes (2)
- [F1]Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on January 22, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on January 22, 2025 of $1.15/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.
- [F2]Includes: (a) 587,416 shares resulting from the January 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, and the remaining 1,000,000 shares will vest in successive equal quarterly installments through January 22, 2026, (b) 21,000 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in one final installment on February 25, 2025 and (c) 73,735 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001675687
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:05 PM ET
- Size
- 6.2 KB